Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results-MedSci.cn

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results

Roth, A; Barcellini, W; D'Sa, S; Miyakawa, Y; Broome, CM; Michel, M; Kuter, DJ; Jilma, B; Tvedt, THA; Weitz, IC; Patel, P; Jiang, XY; Reuter, C; Su, J; Shafer, F; Lee, M; Berentsen, S

Roth, A (通讯作者)，Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, West German Canc Ctr, Essen, Germany.

HAEMATOLOGICA, 2022; 107 (7): 1698

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results

科室

工具

服务